Recent Company News

• 10:41 AM ET Apr 01, 2026
  

  Transcript Intelligence: Nanobiotix Q4 Earnings Guidance

• 10:41 AM ET Apr 01, 2026
  

  Transcript Intelligence: Nanobiotix Q4 Earnings Themes

• 10:41 AM ET Apr 01, 2026
  

  Transcript Intelligence: Nanobiotix Q4 Earnings Q&A

• 05:52 AM ET Mar 25, 2026
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 02:52 AM ET Apr 01, 2026
  

  StreetAccount Summary - European pre-market trading update

• 04:21 PM ET Mar 31, 2026
  

  Nanobiotix reports FY net income (€24.0M) vs FactSet (€7.9M) [7 est, (€42.4)-23.4M] (€25.85, 0.00)

• 10:38 AM ET Mar 30, 2026
  

  StreetAccount M&A Summary: Week of 23-Mar

• 10:12 AM ET Mar 25, 2026
  

  NANOBIOTIX states that, to the best of its knowledge, there is no such intention to acquire control of the company (€26.70, +1.30)

• 03:47 AM ET Mar 25, 2026
  

  Johnson & Johnson looking at Nanobiotix - La Lettre (€25.40, 0.00)